Physician profile
Whitney Chase
NPI 1821500984
$8,704.12
in general payments reported to CMS, 2019-2025
30 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,882 · 2022: $2,062 · 2023: $1,831 · 2024: $1,579 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,925 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $720 · Consulting Fee: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,924.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $720.00 |
| Consulting Fee | $115.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $980.00 | 2021-2023 | |
| Pfizer INC. | $819.79 | 2023-2025 | |
| Janssen Biotech, INC. | $737.41 | 2022-2025 | Tecvayli, Rybrevant, Talvey |
| Regeneron Healthcare Solutions, INC. | $606.96 | 2021-2025 | Libtayo |
| Glaxosmithkline, LLC. | $587.46 | 2021-2023 | Ojjaara |
| Incyte Corporation | $583.20 | 2022-2025 | Niktimvo, Monjuvi, Jakafi |
| Genmab U.S., INC. | $572.74 | 2023-2025 | Epkinly |
| Adaptive Biotechnologies Corporation | $405.16 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $340.74 | 2024-2025 | Talvey, Tecvayli, Darzalex |
| Beigene USA, INC. | $325.87 | 2021-2024 | Brukinsa |
| Gilead Sciences, INC. | $229.13 | 2024-2025 | Trodelvy |
| Jazz Pharmaceuticals INC. | $221.31 | 2021 | |
| Seagen INC. | $213.27 | 2022 | |
| Celgene Corporation | $203.37 | 2021-2023 | Reblozyl |
| Genentech USA, INC. | $188.07 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $139.17 | 2025 | Imdelltra (Amg757) |
| Merck Sharp & Dohme LLC | $125.00 | 2025 | Welireg |
| Sobi, INC | $125.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $124.52 | 2022 | |
| Myovant Sciences INC. | $124.11 | 2022 | |
| Exelixis INC. | $121.94 | 2025 | Cabometyx |
| Blueprint Medicines Corporation | $121.88 | 2022 | |
| Genzyme Corporation | $120.19 | 2021 | |
| Daiichi Sankyo INC. | $119.74 | 2024 | |
| Rigel Pharmaceuticals, INC. | $116.72 | 2024 | Rezlidhia, Tavalisse |
| Kite Pharma, INC. | $108.65 | 2022 | |
| Astellas Pharma US INC | $105.79 | 2021 | |
| Adc Therapeutics America, INC. | $95.32 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $85.45 | 2025 | Onivyde |
| Novartis Pharmaceuticals Corporation | $56.16 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Chase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.